Description
Davalintide ELISA for estimation in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and others. Davalintide, a novel amylin-mimetic peptide, is an amylinomimetic with increased potency, efficacy, and duration of action, binding with high affinity to amylin, calcitonin and calcitonin gene-related peptide receptors. Amylin affects glucose control through several mechanisms, including slowed gastric emptying, regulation of postprandial glucagon, and reduction of food intake, and Davalintide is under investigation for diabetes mellitus.
If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!